The Influence of Treated and Untreated Subclinical Hypothyroidism on Metabolic Profile in Women with Polycystic Ovary Syndrome
Table 2
Anthropometric, thyroid, and metabolic characteristics in PCOS women in accordance with nutritional status. Each of the 3 groups untreated SCH, treated SCH, and control group was divided into two subgroups: patients with normal BMI (BMI <25) and patients with overweight/obesity (BMI ≥25).
Variable
Group
Non-treatment
Treatment
Control
Normal BMI n = 21
BMI ≥25 n = 17
Normal BMI n = 32
BMI ≥25 n = 44
Normal BMI n = 49
BMI ≥25 n = 27
Age (years)
24.57 ± 3.93
23.76 ± 4.56
25.06 ± 4.20
25.36 ± 4.39
24.53 ± 3.48
25.30 ± 4.63
BMI (kg/m2)
21.25 ± 2.07
32.25 ± 6.08
21.51 ± 2.15
31.20 ± 3.28
21.18 ± 1.71
32.07 ± 5.91
TSH (mIU/L) (0.27–4.2)
5.29 ± 1.23
5.93 ± 1.85
1.94 ± 0.89
2.20 ± 0.94
1.68 ± 0.52
1.50 ± 0.90
CHOL (mmol/l) (<5.2)
4.56 ± 0.67
5.3 ± 1.04
4.71 ± 0.97
4.82 ± 0.86
4.71 ± 0.77
4.74 ± 1.06
HDL-C (mmol/l) (>1)
1.48 ± 0.42
1.2 ± 0.26
1.49 ± 0.3
1.19 ± 0.29
1.63 ± 0.39
1.63 ± 0.39
LDL-C (mmol/l) (<3.4)
2.56 ± 0.49
3.4 ± 1.08
2.77 ± 0.76
2.9 ± 0.76
2.63 ± 0.64
3.02 ± 0.85
TRIG (mmol/l) (<1.7)
1.17 ± 0.6
1.5 ± 0.51
0.97 ± 0.45
1.59 ± 0.64
1.01 ± 0.4
1.45 ± 1.06
Glucose (mmol/l) (4.08–5.84)
4.7 ± 0.27
4.9 ± 0.41
4.71 ± 0.38
5.0 ± 0.36
4.69 ± 0.57
5.08 ± 0.88
Insulin [uIU/ml] (<24)
7.19 ± 3.38
15.89 ± 7.94
7.25 ± 3.55
12.70 ± 6.40
7.02 ± 2.59
13.84 ± 11.45
HOMA-IR
1.52 ± 0.71
3.51 ± 1.87
1.54 ± 0.80
2.88 ± 1.55
1.49 ± 0.61
3.23 ± 2.63
BMI, body mass index; CHOL, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, light-density lipoprotein cholesterol; TRIG, triglycerides; HOMA-IR, homeostatic assessment of insulin resistance.
